The 13d group will probably wait until the last minute to
The 13d group will probably wait until the last minute to file an appeal like they did for the 13d filing. Then when the clerk is handing the judge the appeal papers.
The judge will laugh and says is this the appeal here? You know you don’t have a court approved time on the docket today This appeal has all the information left out? When are you going to learn you dumb bastards! The paperwork “is” the most important part of lawsuits. Wasn’t there a retired lawyer that was part of this group? Did you get rid of your high dollar law firm? Why is this little old guy (Rosenbaum) here representing this group?
Rosenbaum replies. Yes your honor. We ran out of funds for an appeal and nobody wanted to buy more convertible notes from IncellDX to help fund our appeal. We are having trouble raising even the filing costs. Patterson and I are footing the filing fees on our pride and belief that you screwed up. (Rosenbaum was never good at hiding his feelings.)
Rosenbaum: So your honor, can you see it my way and read what I wrote for the appeal on the napkin at breakfast this morning that I had with the last two investors still included in todays appeal. Your honor the napkin tells it all. We were never going to purchase IncellDX if we were successful in the hostile take over. Notice where it says NADA? That’s the affirmation of not going to buy IncellDX… Just so you know… Patterson’s emails about being acquired by Cytodyn were just jokes we were playing on the group to raise legal funds that we knew we would need. We didn’t feel that the lies that Dr Patterson told the court under oath were that serious and felt you put to much weight on his couple of lies. Just know Dr Patterson has trouble telling the truth on anything but we try to not hold it against him. He comes across so nice… so we overlook his lying. When we catch him stealing we just slap him on the back of his hand and he gets the message. We still like him plenty though.
Judge: Gives disgusted look and says: is this everything you want to dispute included on this little napkin?
Rosenbaum: Yes it is your honor… we had to use half of the napkin to clean up a spill this morning. So what do you think judge… can we have a stay so we can stop the annual shareholders meeting? Then progress to all your mistakes you ruled on so we can correct your view with the appeal?
Judge: Well… I am wondering if you are on a temporary pass from the asylum or some kind of facility that might take care of you. Does your friends have anything to add? Do they know if you have a pass to be off the premises of whatever facility you might of came from? No answer…
Judge: Well, I just have to say that you have a habit of not following the rules and filling out proper paperwork to progress your cases. It will be denied and your Injunction for the stay also denied for your appeal. Do you know why? Because you are not suppose to come back to my court for these actions you seek. You need to follow up in another appeals court and you might want to get some legal advice to know where to go from here. I am not going to rule anything today for you and maybe that will be the end of it. As the gavel drops… Bam!
I just had to have some fun at the 13d’s expense. I realize people are tired or them and the subject overall.
Wishing it was the end of the 13d but they are still around causing us trouble and hopefully the next 6 months allows us a break from all the negativity. They will run a campaign to vote against whatever makes sense just to try to trip up the management and force the company to fail. They are not finished with us and we can’t turn our back on them just yet.
Be aware that they will run a campaign against the 200 million shares we absolutely need to further the trials and buy the next big batch of Leronlimab. Before revenue allows us to buy what we need when we need it. Nader promised us minimal dilution with the yes vote on those shares. Nader has done a good job of minimizing dilution in the past. We should feel good about authorizing the 200 million shares. Nobody likes dilution but this is necessary or we fail as a company. There is no way we progress without those shares. Don’t let the Remnants of the 13d group convince you we should vote no on those shares. They are out to make us fail if they can. So they can swoop in and steal Leronlimab… you know it and I know it. Let’s not let it happen. Be smart investors and don’t listen to that group. The next 6 months will be one heck of a ride. We have 16 things to look forward to. Amazing!
10
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...
Continue Reading
A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...
Continue Reading
Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...
Continue Reading
WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...
Continue Reading
Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...
Continue Reading
An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...
Continue Reading
What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...
Continue Reading
Index Shake-Up: Who's In, Who's Out? Hold onto your hats, folks—big changes are coming to the S&P MidCap 400! Chime Financial Inc. is crashing the party, taking a seat at the table, as NorthWestern Energy Group gets the boot. Now, if that doesn’t grab your attention, I don’t know what will. You've got to appreciate the chaos and opportunities that come with a roster...
Continue Reading
Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...
Continue Reading
KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...
Continue Reading
Top 5 Most Recently Viewed Articles
Recordati's Strategic Plan for 2025-2027 Recordati S.p.A. has launched an extensive three-year plan aimed at enhancing its product offerings and significant growth by 2027. With ambitious targets set, the company is poised to achieve revenues ranging from €3,000 to €3,200 million, signaling strong confidence in its operational strategies and market potential. Growth...
Continue Reading
Understanding Major Shareholding Notifications In the world of finance, shareholding notifications are vital for maintaining transparency in market activities. They provide insights into changes in major shareholders and their voting rights, shaping the corporate governance landscape. We will explore recent notifications affecting PAYPOINT PLC, shedding light on the vital...
Continue Reading
JBL Elevates Party Experience with New PartyBox Lineup JBL has long been synonymous with extraordinary audio experiences, and its latest PartyBox lineup is a testament to this dedication. With their introduction, JBL solidifies its dominance as the leading brand in party speakers, perfectly crafted to amplify any gathering. These innovative speakers deliver an unmatched...
Continue Reading
Benevity Welcomes Soraya Alexander as New Chief Executive Officer CALGARY, Alberta — Benevity, Inc., renowned as a leader in social impact software, is thrilled to announce the appointment of Soraya Alexander as its new Chief Executive Officer (CEO), effective November 1. Alexander brings a wealth of experience, having recently served as the President of GoFundMe Pro....
Continue Reading
Karooooo Ltd's Earnings Report Impact U.S. stock futures showed some fluctuations recently, with the Dow futures dipping significantly early in the session. Karooooo Ltd (NASDAQ: KARO) reflected this trend by experiencing a notable drop in its stock price after releasing its latest earnings report, which disappointed some investors. Quarterly Earnings Snapshot In its...
Continue Reading